1 alpha-hydroxyvitamin D3 treatment of three patients with 1,25-dihydroxyvitamin D-receptor-defect rickets and alopecia
- PMID: 3037475
1 alpha-hydroxyvitamin D3 treatment of three patients with 1,25-dihydroxyvitamin D-receptor-defect rickets and alopecia
Abstract
Three patients with clinically different severities of vitamin D-dependent rickets, type II, with alopecia, which is 1,25-dihydroxyvitamin D-receptor-defect rickets and is particularly resistant to treatment with calciferol analogues, were treated with large doses of 1 alpha-hydroxyvitamin D3 (1 alpha-(OH)D3) and 2 g of calcium lactate. Except for the alopecia, all of the abnormalities of patients 1 and 2 were reversed by treatment with 3 micrograms/kg/d of 1 alpha-(OH)D3, and those of patient 3, who had the severest manifestations, were reversed by treatment with 6 micrograms/kg/d. The serum 24,25-dihydroxyvitamin D concentrations of the three patients were low before treatment and those of patients 1 and 2 increased during treatment. These findings suggest that in patients 1 and 2, 25-hydroxyvitamin D-24-hydroxylase was stimulated via a 1,25-dihydroxyvitamin D-receptor-mediated system by treatment with 1 alpha-(OH)D3.
Similar articles
-
Rickets and alopecia with resistance to 1,25-dihydroxyvitamin D: two different clinical courses with two different cellular defects.J Clin Endocrinol Metab. 1983 Oct;57(4):803-11. doi: 10.1210/jcem-57-4-803. J Clin Endocrinol Metab. 1983. PMID: 6309886
-
[Vitamin D-resistant rickets type II: apropos of 2 cases].Pediatrie. 1992;47(12):817-20. Pediatrie. 1992. PMID: 1338926 French.
-
Vitamin D-dependent rickets types I and II. Diagnosis and response to therapy.Isr J Med Sci. 1985 Jan;21(1):53-6. Isr J Med Sci. 1985. PMID: 2982764
-
The combined use of intravenous and oral calcium for the treatment of vitamin D dependent rickets type II (VDDRII).Clin Endocrinol (Oxf). 1993 Aug;39(2):229-37. doi: 10.1111/j.1365-2265.1993.tb01779.x. Clin Endocrinol (Oxf). 1993. PMID: 8396512 Review.
-
Clinical features of hereditary resistance to 1,25-dihydroxyvitamin D (hereditary hypocalcemic vitamin D resistant rickets type II).Adv Exp Med Biol. 1986;196:391-406. doi: 10.1007/978-1-4684-5101-6_26. Adv Exp Med Biol. 1986. PMID: 3012981 Review. No abstract available.
Cited by
-
Hereditary vitamin D resistant rickets caused by a novel mutation in the vitamin D receptor that results in decreased affinity for hormone and cellular hyporesponsiveness.J Clin Invest. 1997 Jan 15;99(2):297-304. doi: 10.1172/JCI119158. J Clin Invest. 1997. PMID: 9005998 Free PMC article.
-
The exposome impact on hair health: non-pharmacological management. Part II⋆.An Bras Dermatol. 2025 Mar-Apr;100(2):322-327. doi: 10.1016/j.abd.2024.08.006. Epub 2025 Jan 14. An Bras Dermatol. 2025. PMID: 39814670 Free PMC article. Review.
-
Two siblings with vitamin-D-dependent rickets type II: no recurrence of rickets for 14 years after cessation of therapy.Eur J Pediatr. 1989 Oct;149(1):54-7. doi: 10.1007/BF02024336. Eur J Pediatr. 1989. PMID: 2558018
-
Clinical and biochemical findings in parents of children with vitamin D-dependent rickets Type II.J Inherit Metab Dis. 1991;14(2):231-40. doi: 10.1007/BF01800596. J Inherit Metab Dis. 1991. PMID: 1653381
-
The Role of Vitamins and Minerals in Hair Loss: A Review.Dermatol Ther (Heidelb). 2019 Mar;9(1):51-70. doi: 10.1007/s13555-018-0278-6. Epub 2018 Dec 13. Dermatol Ther (Heidelb). 2019. PMID: 30547302 Free PMC article. Review.